Publications by authors named "Mathilde Hunault Berger"

Claim this Profile
C
Clusterin and pentraxin 3 are markers of severity during febrile neutropenia in adults with haematological malignancies receiving intensive chemotherapy.
Coralie Mallebranche, Carole Mosnier, Corentin Orvain, Jérémie Riou, Sylvain Thepot, Mathilde Hunault-Berger

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia.
Delphine Lebon, Audrey Da Rocha, Bruno Cassinat, Maël Heiblig, Sarah Bertoli, Mathilde Hunault-Berger

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia.
Carole Mosnier, Sarah Bellal, Laurane Cottin, Françoise Boyer, Sandrine Lemoine, Mathilde Hunault-Berger

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual peripheral T-cell lymphoma with a cytotoxic phenotype presenting in the pancreas.
Juliette Dubois, Sarah Bellal, Marie-Christine Copin, Paul Mallet-Guy, Clément Bouron, Mathilde Hunault-Berger

Ann Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Patrice Chevallier, Thibaut Leguay, Marc Delord, Cyril Salek, Rathana Kim, Mathilde Hunault-Berger

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study.
Corentin Orvain, Sarah Bertoli, Pierre Peterlin, Yohann Desbrosses, Pierre-Yves Dumas, Mathilde Hunault-Berger

Leukemia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Mitja Nabergoj, Diderik-Jan Eikema, Linda Koster, Uwe Platzbecker, Katja Sockel, Mathilde Hunault-Berger

Bone Marrow Transplant· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.
Alicia Rovó, Luuk Gras, Brian Piepenbroek, Nicolaus Kröger, H Christian Reinhardt, Mathilde Hunault-Berger

Am J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Corentin Orvain, Sylvain Chantepie, Xavier Thomas, Martine Escofrre-Barbe, Francoise Huguet, Mathilde Hunault-Berger

Haematologica· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma.
Agathe Vély, Marie-Anne Couturier, Pascal Delepine, Ronan Le Calloch, Marjan Ertault, Mathilde Hunault-Berger

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning.
Agathe Vely, Jérôme Paillassa, Christopher Nunes Gomes, Aurélien Giltat, Sophie Fouquet, Mathilde Hunault-Berger

Ann Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK inhibition for CD3 CD4 lymphocytic-variant hypereosinophilic syndrome.
Stanislas Faguer, Matthieu Groh, François Vergez, Mathilde Hunault-Berger, Nicolas Duployez

Clin Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores.
Amélie Bachelot, Anne Bouvier, Jérémie Riou, Sylvain Thepot, Aurélien Giltat, Mathilde Hunault-Berger

Am J Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center study.
Christophe Desprez, Achille Kouatchet, Tony Marchand, Jean Baptiste Mear, Jean Marc Tadié, Mathilde Hunault-Berger

Ann Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a new blood cultures sampling strategy in patients receiving intensive chemotherapy for acute leukemia and/or hematopoietic cell transplantation.
Charles Declerck, Aurélien Giltat, Romane Boutemy, Marie Brisset-Dheilly, Anais Pelhatre, Mathilde Hunault-Berger

Leuk Lymphoma· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Guillermo Ortí, Luuk Gras, Nienke Zinger, Maria Chiara Finazzi, Katja Sockel, Mathilde Hunault-Berger

Am J Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia-a Grand Ouest Against Leukemia (GOAL) study.
Christophe Desprez, Jérémie Riou, Pierre Peterlin, Tony Marchand, Marie-Anne Couturier, Mathilde Hunault-Berger

Leukemia· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemia.
Corentin Orvain, Megan Othus, Gurleen Johal, Mathilde Hunault-Berger, Frederick R Appelbaum

Leukemia· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive multifocal leukoencephalopathy after durvalumab treatment for acute myeloid leukemia: A consequence of an immune reconstitution inflammatory syndrome?
Emeline Vinatier, Caroline Poli, Aurélien Giltat, Christopher Nunes-Gomes, Corentin Orvain, Mathilde Hunault-Berger

EJHaem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT.
Mitja Nabergoj, Katya Mauff, Dietrich Beelen, Arnold Ganser, Nicolaus Kröger, Mathilde Hunault-Berger

Bone Marrow Transplant· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.
Damien Luque Paz, Laurane Cottin, Eric Lippert, Jean-Baptiste Robin, Charles Bescond, Mathilde Hunault-Berger

Ann Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial.
Guillaume Drevin, Marie Briet, Caroline Bazzoli, Emmanuel Gyan, Aline Schmidt, Mathilde Hunault-Berger

Pharmaceutics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study.
Raynier Devillier, Edouard Forcade, Alice Garnier, Sarah Guenounou, Sylvian Thepot, Mathilde Hunault-Berger

Blood Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Johannes Schetelig, Patrice Chevallier, Michel van Gelder, Jennifer Hoek, Olivier Hermine, Mathilde Hunault-Berger

Bone Marrow Transplant· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis.
Stéphane de Botton, Joseph M Brandwein, Andrew H Wei, Arnaud Pigneux, Bruno Quesnel, Mathilde Hunault-Berger

Cancer Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis